| UniProt ID | PPR18_HUMAN | |
|---|---|---|
| UniProt AC | Q6NYC8 | |
| Protein Name | Phostensin | |
| Gene Name | PPP1R18 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 613 | |
| Subcellular Localization |
Isoform 1: Cytoplasm, cytoskeleton . Isoform 4: Cytoplasm, cytoskeleton . |
|
| Protein Description | Isoform 1: May target protein phosphatase 1 to F-actin cytoskeleton.; Isoform 4: May target protein phosphatase 1 to F-actin cytoskeleton.. | |
| Protein Sequence | MATIPDWKLQLLARRRQEEASVRGREKAERERLSQMPAWKRGLLERRRAKLGLSPGEPSPVLGTVEAGPPDPDESAVLLEAIGPVHQNRFIRQERQQQQQQQQRSEELLAERKPGPLEARERRPSPGEMRDQSPKGRESREERLSPRETRERRLGIGGAQELSLRPLEARDWRQSPGEVGDRSSRLSEAWKWRLSPGETPERSLRLAESREQSPRRKEVESRLSPGESAYQKLGLTEAHKWRPDSRESQEQSLVQLEATEWRLRSGEERQDYSEECGRKEEWPVPGVAPKETAELSETLTREAQGNSSAGVEAAEQRPVEDGERGMKPTEGWKWTLNSGKAREWTPRDIEAQTQKPEPPESAEKLLESPGVEAGEGEAEKEEAGAQGRPLRALQNCCSVPSPLPPEDAGTGGLRQQEEEAVELQPPPPAPLSPPPPAPTAPQPPGDPLMSRLFYGVKAGPGVGAPRRSGHTFTVNPRRSVPPATPATPTSPATVDAAVPGAGKKRYPTAEEILVLGGYLRLSRSCLAKGSPERHHKQLKISFSETALETTYQYPSESSVLEELGPEPEVPSAPNPPAAQPDDEEDEEELLLLQPELQGGLRTKALIVDESCRR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 21 | Phosphorylation | RRRQEEASVRGREKA HHHHHHHHHHHHHHH | 18.67 | - | |
| 23 | Methylation | RQEEASVRGREKAER HHHHHHHHHHHHHHH | 35.64 | 82797691 | |
| 40 | Acetylation | LSQMPAWKRGLLERR HHCCHHHHHHHHHHH | 38.40 | 26051181 | |
| 41 | Methylation | SQMPAWKRGLLERRR HCCHHHHHHHHHHHH | 30.23 | 115387127 | |
| 54 | Phosphorylation | RRAKLGLSPGEPSPV HHHHCCCCCCCCCCC | 29.12 | 25159151 | |
| 59 | Phosphorylation | GLSPGEPSPVLGTVE CCCCCCCCCCCCEEE | 24.28 | 21712546 | |
| 64 | Phosphorylation | EPSPVLGTVEAGPPD CCCCCCCEEECCCCC | 15.83 | 24732914 | |
| 75 | Phosphorylation | GPPDPDESAVLLEAI CCCCCCHHHHHHHHH | 30.93 | 24732914 | |
| 125 | Phosphorylation | EARERRPSPGEMRDQ CHHHCCCCCCCCCCC | 43.66 | 29255136 | |
| 133 | Phosphorylation | PGEMRDQSPKGRESR CCCCCCCCCCCCCCH | 32.63 | 23401153 | |
| 139 | Phosphorylation | QSPKGRESREERLSP CCCCCCCCHHHHCCH | 43.56 | 24732914 | |
| 145 | Phosphorylation | ESREERLSPRETRER CCHHHHCCHHHHHHH | 28.29 | 23401153 | |
| 163 | Phosphorylation | IGGAQELSLRPLEAR CCCCCCCCCCCCCCC | 22.91 | 20068231 | |
| 175 | Phosphorylation | EARDWRQSPGEVGDR CCCCHHCCCCCCCCC | 26.71 | 29255136 | |
| 183 | Phosphorylation | PGEVGDRSSRLSEAW CCCCCCCHHHHHHHH | 25.26 | 22199227 | |
| 184 | Phosphorylation | GEVGDRSSRLSEAWK CCCCCCHHHHHHHHH | 37.83 | 22199227 | |
| 187 | Phosphorylation | GDRSSRLSEAWKWRL CCCHHHHHHHHHCCC | 24.94 | 25159151 | |
| 195 | Phosphorylation | EAWKWRLSPGETPER HHHHCCCCCCCCHHH | 23.45 | 22167270 | |
| 199 | Phosphorylation | WRLSPGETPERSLRL CCCCCCCCHHHHHHH | 36.04 | 29255136 | |
| 203 | O-linked_Glycosylation | PGETPERSLRLAESR CCCCHHHHHHHHHHH | 19.04 | 23301498 | |
| 203 | Phosphorylation | PGETPERSLRLAESR CCCCHHHHHHHHHHH | 19.04 | 18212344 | |
| 209 | Phosphorylation | RSLRLAESREQSPRR HHHHHHHHHCCCCCH | 35.19 | 25159151 | |
| 213 | Phosphorylation | LAESREQSPRRKEVE HHHHHCCCCCHHHHH | 18.67 | 28355574 | |
| 221 | Phosphorylation | PRRKEVESRLSPGES CCHHHHHHHCCCCHH | 43.63 | 23927012 | |
| 224 | Phosphorylation | KEVESRLSPGESAYQ HHHHHHCCCCHHHHH | 29.74 | 29255136 | |
| 228 | Phosphorylation | SRLSPGESAYQKLGL HHCCCCHHHHHHHCC | 37.89 | 23927012 | |
| 230 | Phosphorylation | LSPGESAYQKLGLTE CCCCHHHHHHHCCCH | 18.56 | 25159151 | |
| 245 | Phosphorylation | AHKWRPDSRESQEQS HHCCCCCCHHHHHHH | 40.40 | 28348404 | |
| 248 | Phosphorylation | WRPDSRESQEQSLVQ CCCCCHHHHHHHHHH | 37.60 | 27251275 | |
| 265 | Phosphorylation | ATEWRLRSGEERQDY HHHHHHHCCCHHCCH | 55.97 | 28857561 | |
| 272 | Phosphorylation | SGEERQDYSEECGRK CCCHHCCHHHHCCCC | 15.05 | 28796482 | |
| 273 | Phosphorylation | GEERQDYSEECGRKE CCHHCCHHHHCCCCC | 34.90 | 28796482 | |
| 296 | Phosphorylation | PKETAELSETLTREA CHHHHHHHHHHHHHH | 21.75 | 29255136 | |
| 298 | Phosphorylation | ETAELSETLTREAQG HHHHHHHHHHHHHCC | 30.01 | 29255136 | |
| 300 | Phosphorylation | AELSETLTREAQGNS HHHHHHHHHHHCCCC | 33.61 | 29255136 | |
| 307 | Phosphorylation | TREAQGNSSAGVEAA HHHHCCCCCCCCHHH | 28.52 | 29978859 | |
| 308 | Phosphorylation | REAQGNSSAGVEAAE HHHCCCCCCCCHHHH | 32.80 | 25159151 | |
| 335 | Phosphorylation | PTEGWKWTLNSGKAR CCCCCEEECCCCCCC | 16.60 | 23403867 | |
| 338 | Phosphorylation | GWKWTLNSGKAREWT CCEEECCCCCCCCCC | 44.79 | 23312004 | |
| 353 | Phosphorylation | PRDIEAQTQKPEPPE HHHHHHHHCCCCCCH | 45.68 | 26074081 | |
| 355 | Acetylation | DIEAQTQKPEPPESA HHHHHHCCCCCCHHH | 55.53 | 26051181 | |
| 361 | Phosphorylation | QKPEPPESAEKLLES CCCCCCHHHHHHHHC | 47.72 | 22199227 | |
| 368 | Phosphorylation | SAEKLLESPGVEAGE HHHHHHHCCCCCCCC | 27.24 | 29255136 | |
| 398 | Phosphorylation | RALQNCCSVPSPLPP HHHHHHCCCCCCCCH | 38.98 | 29255136 | |
| 401 | Phosphorylation | QNCCSVPSPLPPEDA HHHCCCCCCCCHHHC | 36.59 | 29255136 | |
| 410 | Phosphorylation | LPPEDAGTGGLRQQE CCHHHCCCCCCCHHH | 29.78 | 27080861 | |
| 432 | Phosphorylation | PPPPAPLSPPPPAPT CCCCCCCCCCCCCCC | 34.01 | 28355574 | |
| 439 | Phosphorylation | SPPPPAPTAPQPPGD CCCCCCCCCCCCCCC | 53.74 | 28102081 | |
| 450 | Phosphorylation | PPGDPLMSRLFYGVK CCCCCCHHHHHHCCC | 33.25 | 22199227 | |
| 454 | Phosphorylation | PLMSRLFYGVKAGPG CCHHHHHHCCCCCCC | 26.12 | - | |
| 457 | Ubiquitination | SRLFYGVKAGPGVGA HHHHHCCCCCCCCCC | 43.17 | - | |
| 457 | Acetylation | SRLFYGVKAGPGVGA HHHHHCCCCCCCCCC | 43.17 | 25953088 | |
| 466 | Methylation | GPGVGAPRRSGHTFT CCCCCCCCCCCCCEE | 44.88 | 115387135 | |
| 468 | Phosphorylation | GVGAPRRSGHTFTVN CCCCCCCCCCCEEEC | 35.88 | 28857561 | |
| 471 | Phosphorylation | APRRSGHTFTVNPRR CCCCCCCCEEECCCC | 25.24 | 29449344 | |
| 473 | Phosphorylation | RRSGHTFTVNPRRSV CCCCCCEEECCCCCC | 22.11 | 29449344 | |
| 479 | Phosphorylation | FTVNPRRSVPPATPA EEECCCCCCCCCCCC | 40.01 | 23403867 | |
| 484 | Phosphorylation | RRSVPPATPATPTSP CCCCCCCCCCCCCCC | 21.16 | 26055452 | |
| 487 | Phosphorylation | VPPATPATPTSPATV CCCCCCCCCCCCCCC | 28.44 | 26055452 | |
| 489 | Phosphorylation | PATPATPTSPATVDA CCCCCCCCCCCCCCC | 42.88 | 29255136 | |
| 490 | Phosphorylation | ATPATPTSPATVDAA CCCCCCCCCCCCCCC | 17.46 | 29255136 | |
| 493 | Phosphorylation | ATPTSPATVDAAVPG CCCCCCCCCCCCCCC | 23.46 | 29255136 | |
| 508 | Phosphorylation | AGKKRYPTAEEILVL CCCCCCCCHHHHHHH | 37.45 | - | |
| 522 | Phosphorylation | LGGYLRLSRSCLAKG HCHHHHHHHHHHHCC | 18.73 | 27251275 | |
| 524 | O-linked_Glycosylation | GYLRLSRSCLAKGSP HHHHHHHHHHHCCCH | 15.31 | 23301498 | |
| 524 | Phosphorylation | GYLRLSRSCLAKGSP HHHHHHHHHHHCCCH | 15.31 | 23403867 | |
| 530 | Phosphorylation | RSCLAKGSPERHHKQ HHHHHCCCHHHHHCE | 23.92 | 23401153 | |
| 557 | O-linked_Glycosylation | TYQYPSESSVLEELG HCCCCCHHHHHHHHC | 30.04 | 23301498 | |
| 603 | Ubiquitination | LQGGLRTKALIVDES HCCCCCCCEEEEEHH | 34.46 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PPR18_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PPR18_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PPR18_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| FAM9B_HUMAN | FAM9B | physical | 25416956 | |
| SPERT_HUMAN | SPERT | physical | 25416956 | |
| CCD57_HUMAN | CCDC57 | physical | 25416956 | |
| GELS_HUMAN | GSN | physical | 26186194 | |
| PP1B_HUMAN | PPP1CB | physical | 26186194 | |
| OGA_HUMAN | MGEA5 | physical | 26186194 | |
| DOCK7_HUMAN | DOCK7 | physical | 26186194 | |
| RAIN_HUMAN | RASIP1 | physical | 26186194 | |
| PCBP3_HUMAN | PCBP3 | physical | 26186194 | |
| TRI27_HUMAN | TRIM27 | physical | 21516116 | |
| RAIN_HUMAN | RASIP1 | physical | 28514442 | |
| PP1B_HUMAN | PPP1CB | physical | 28514442 | |
| PCBP3_HUMAN | PCBP3 | physical | 28514442 | |
| GELS_HUMAN | GSN | physical | 28514442 | |
| OGA_HUMAN | MGEA5 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-368, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-54; SER-175; SER-195;THR-199 AND SER-224, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-195; SER-224 ANDSER-368, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-195, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125; SER-133; SER-145;SER-265; SER-368 AND SER-530, AND MASS SPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-432, AND MASSSPECTROMETRY. | |